1Dr. Vincenzo Francesco MD,Giampaolo Angelini MD,Paolo Bovo MD,Maria Beatrice Casarini MD,Marco Filippini MD,Bruna Vaona MD,Luca Frulloni MD,Laura Rigo MD,Maria Paola Brunori MD,Giorgio Cavallini MD. Effect of octreotide on sphincter of oddi motility in patients with acute recurrent pancreatitis[J] 1996,Digestive Diseases and Sciences(12):2392～2396
2Haim Paran M.D.,David Neufeld M.D.,Ofer Kaplan M.D.,Joseph Klausner M.D.,Uri Freund M.D.. Octreotide for treatment of postoperative alimentary tract fistulas[J] 1995,World Journal of Surgery(3):430～433
3Kenneth F. Binmoeller MD,Remy Dumas MD,Alan G. Harris MD,Prof. J. P. Delmont MD. Effect of somatostatin analog octreotide on human sphincter of Oddi[J] 1992,Digestive Diseases and Sciences(5):773～777
7Dc Aretxabala X, Losada tI, MoraJ, et al. Neoadjuvant chemoradiotherapy in gallbladder cancer. Rev Med Chil, 2004, 132: 51-57.
8Hejna M, Zielinski CC. Nonsurgical management of gallbladder cancer by cytotoxic treatment and radiotherapy. Expert Rev Anticancer Ther, 2001,1:291-300.
9Li JY, Quan ZW, Zhang Q, et al. The synergistic inhibitory effect of somatostatin--doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer, 2007,7:125.
10Reubi JC. Krenning E, Lamberts SW, et al. In vitro detection of somatostalin receptors in human tumors. Digestion, 1993, 19:76-83.
